Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL)
PubMed Full text in PMC Similar studies Analyze with GEO2R
Chronic lymphocytic leukemia: peripheral blood, bone marrow and lymph node matched samples
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Novel spirocyclic dimer, SpiD3, targets critical tumor survival pathways and displays potent preclinical activity in B-cell chronic lymphocytic leukemia
Gene expression study in CLL of B-cell receptor triggering
Gene expression study in CLL of B-cell receptor triggering (miRNA study)
PubMed Full text in PMC Similar studies
Gene expression study in CLL of B-cell receptor triggering (mRNA Study)
Transcriptome analysis of murine B cell and CLL samples
PubMed Full text in PMC Similar studies SRA Run Selector
Inhibitor of apoptosis proteins as promising therapeutic targets in chronic lymphocytic leukemia
PubMed Similar studies Analyze with GEO2R
Inhibitor of apoptosis protein antagonist BV6 – potential for new combinatorial treatment strategies in acute myeloid leukemia
Chronic lymphocytic leukemia cells response to the neutralization of inhibitor of apoptosis proteins
PubMed Similar studies GEO Profiles Analyze DataSet
Gene signature of CLL cells cultured with activated T cells or CD40L-expressing cells
MLN4924 in chronic lymphocytic leukemia
CD40 stimulation + dasatinib treatment of chronic lymphocytic leukemia (CLL) cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on